Search results

General Mills, Inc. GIS is leaning on a strategic pivot toward heightened innovation and brand investment to revitalize its top-line performance. As part of its "Remarkable Experience Framework,"

Ondas Inc. ONDS has delivered an eye-catching run, with shares up 1304.6% over the past year and 8.1% year to date as of April 24, 2026.

That kind of move can change the entry-timing math. The stock

TTM Technologies TTMI is gaining momentum as demand from artificial intelligence (AI) and defense markets accelerates. These structural tailwinds are increasing system complexity and extending

Even though Intel INTC was once the world’s largest semiconductor company, the chip giant is on the cusp of an improbable turnaround.

Notably, Wall Street’s tone has flipped from “Intel is dying”

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

ImmunityBio IBRX is moving from a U.S.-led launch to a broader international rollout. Authorizations now span the United States, the United Kingdom, the European Union, Saudi Arabia, and Macau

Investors might want to bet on Docebo Inc. (DCBO), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum

Investors might want to bet on Cass Information Systems (CASS), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price

The first-quarter 2026 reporting cycle for the Medical sector is about to accelerate, as most companies are scheduled to release results over the next two weeks. The earnings season for the drug and

Shares of Organon OGN jumped 16% in pre-market trading after the company and India’s Sun Pharmaceutical Industries Limited jointly announced a definitive agreement. Per the agreement, Sun Pharma

Investors will focus on profits from asthma drug Dupixent and sales of Eylea HD when biotech giant Regeneron Pharmaceuticals, Inc. REGN reports first-quarter 2026 results on April 29, 2026.

The

GE Vernova GEV and American Electric Power AEP share a strong strategic connection through their focus on transmission infrastructure and large-scale grid expansion. As electricity demand rises

GE Aerospace GE and Howmet Aerospace Inc. HWM are two prominent names operating in the aerospace and defense industry. As rivals, both companies are engaged in producing highly engineered aircraft

Investors might want to bet on FTAI Aviation (FTAI), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is

Investors might want to bet on Laird Superfood, Inc. (LSF), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is

Vertiv Holdings Co. (VRT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting

ImmunityBio (IBRX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the